Details for 2017781425
Up to date per 05.04.2026
Actions
Details for 2017781425
Granted/Registered
European Patent
07.08.2019 A
19.07.2023 B1
29.09.2016
EP
16191451
13.02.2017
EP
17155843
A61K 38/29 20060101AFI20211006BHEP
Owner
Ascendis Pharma Bone Diseases A/STuborg Boulevard 12 2900 HellerupDK
Representative
Representative
Dr. Müllner Dipl.-Ing. Katschinka OG, PatentanwaltskanzleiWeihburggasse 9/241010 WienAT
Inventor
HOLTEN-ANDERSEN, Lars 2900 HellerupDK
SPROGØE, Kennett 2900 HellerupDK
KARPF, David Brian Palo Alto, CA 94304US
Information about Fees